Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles. [electronic resource]
Producer: 20110317Description: 610-9 p. digitalISSN:- 1537-6613
- AIDS Vaccines -- immunology
- Adolescent
- Adult
- CD4 Lymphocyte Count
- CD4-Positive T-Lymphocytes -- immunology
- CD8-Positive T-Lymphocytes -- immunology
- Double-Blind Method
- Drug Administration Schedule
- Enzyme-Linked Immunosorbent Assay
- Female
- Genetic Vectors
- HIV Antibodies -- biosynthesis
- HIV Infections -- prevention & control
- HIV-1 -- immunology
- Humans
- Male
- Middle Aged
- Placebos
- United States
- Vaccines, DNA -- immunology
- Vaccinia virus -- genetics
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.